Once-weekly prophylaxis regimen of nonacog alfa in patients with hemophilia B: an analysis of timing of bleeding event onset.

Tortella, Bartholomew J; Carr, Marcus E; Rendo, Pablo; Korth-Bradley, Joan; Smith, Lynne M; Kavakli, Kaan

Tortella, Bartholomew J; Carr, Marcus E; Rendo, Pablo; Korth-Bradley, Joan; Smith, Lynne M; Kavakli, Kaan.

Affiliation

Tortella BJ; Pfizer Inc., Collegeville, Pennsylvania, USA.
Carr ME; Pfizer Inc., Collegeville, Pennsylvania, USA.
Rendo P; Pfizer Inc., Collegeville, Pennsylvania, USA.
Korth-Bradley J; Pfizer Inc., Collegeville, Pennsylvania, USA.
Smith LM; Pfizer Inc., Collegeville, Pennsylvania, USA.
Kavakli K; Department of Pediatric Hematology, University of Ege, Izmir, Turkey.

Blood Coagul Fibrinolysis ; 32(3): 180-185, 2021 Apr 01.

Article in En | MEDLINE | ID: mdl-33631774

Subject(s)

Hemophilia B/drug therapy; Hemorrhage/prevention & control; Adolescent; Adult; Drug Administration Schedule; Female; Hemarthrosis/etiology; Hemarthrosis/prevention & control; Hemophilia B/complications; Hemorrhage/etiology; Humans; Male; Middle Aged; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemophilia B / Hemorrhage Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2021 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google